SCHEMBL2450372

SCHEMBL2450372

CN1CCOc2cc(/C=N\O)cc(Cl)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
GRM5 P41594 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 3/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
MYC P01106 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TRPM5 Q9NZQ8 1/20 0.32
NPC1 O15118 1/20 0.31
THRB P10828 1/20 0.31
RAB9A P51151 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2450374 1.00 ALDH1A1 (0.36) ALDH1A1GRM5CYP1A2CYP3A4PKM
SCHEMBL14744980 0.75 MYC (0.50) ALDH1A1GRM5HTTHPGDMEN1
SCHEMBL16440970 0.75 MYC (0.50) ALDH1A1GRM5HTTHPGDMEN1
SCHEMBL14744979 0.75 MYC (0.50) ALDH1A1GRM5HTTHPGDMEN1
SCHEMBL12330731 0.74 L3MBTL1 (0.36) ALDH1A1GRM5PKMGAAMEN1
SCHEMBL2444548 0.73 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4PKMCYP2C19
SCHEMBL2444546 0.73 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4PKMCYP2C19
SCHEMBL12401775 0.71 L3MBTL1 (0.34) GRM5GAAMEN1KMT2AMAPK1
SCHEMBL2162017 0.67 POLB (0.38) ALDH1A1CYP1A2CYP3A4PKMCYP2C19
SCHEMBL20348494 0.66 P2RX7 (0.44) GRM5PKMGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed